Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FLT3 | P36888 | 1/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | MGLL | Q99685 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TYR | P14679 | 1/20 | 0.47 |
| ▸ | DAO | P14920 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | AGXT | P21549 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL103158 | 0.74 | MAOB (0.63) | MAOBKDM4ERAB9AALDH1A1CYP2A6 | |
| SCHEMBL30036439 | 0.74 | MAOB (0.63) | MAOBKDM4ERAB9AALDH1A1CYP2A6 | |
| SCHEMBL31105656 | 0.71 | MAOB (0.71) | MAOBKDM4ERAB9AALDH1A1HPGD | |
| SCHEMBL731363 | 0.71 | MAOB (0.71) | MAOBKDM4ERAB9AALDH1A1HPGD | |
| SCHEMBL316744 | 0.70 | KDM4E (0.48) | MAOBKDM4ERAB9AALDH1A1CYP2A6 | |
| SCHEMBL8874655 | 0.70 | KDM4E (0.48) | MAOBKDM4ERAB9AALDH1A1CYP2A6 | |
| SCHEMBL276909 | 0.70 | CYP2A6 (0.54) | MAOBKDM4ERAB9AALDH1A1CYP2A6 | |
| SCHEMBL21494529 | 0.70 | KDM4E (0.48) | MAOBKDM4ERAB9AALDH1A1CYP2A6 | |
| SCHEMBL2057444 | 0.70 | KDM4E (0.48) | MAOBKDM4ERAB9AALDH1A1CYP2A6 | |
| SCHEMBL12264 | 0.70 | KDM4E (0.48) | MAOBKDM4ERAB9AALDH1A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210070782-A1 | METHOD FOR SYNTHESIZING BORONATE ESTER COMPOUND, SODIUM SALT OF BORONATE ESTER COMPOUND, AND METHOD FOR SYNTHESIZING THE SAME | KOBELCO ECO-SOLUTIONS CO., LTD. (JP) | 2021-03-11 | — | — | US | disclosed |
| EP-3741764-A1 | SYNTHESIS METHOD FOR BORONIC ACID ESTER COMPOUND, AND SODIUM SALT OF BORONIC ACID ESTER COMPOUND AND SYNTHESIS METHOD THEREFOR | Kobelco Eco-Solutions Co., Ltd (JP) | 2020-11-25 | — | — | EP | disclosed |
| CN-111801335-A | Synthesis method of boronic acid ester compound, sodium salt of boronic acid ester compound and synthesis method thereof | 株式会社神钢环境舒立净 | 2020-10-20 | — | — | CN | disclosed |
| WO-2019142854-A1 | SYNTHESIS METHOD FOR BORONIC ACID ESTER COMPOUND, AND SODIUM SALT OF BORONIC ACID ESTER COMPOUND AND SYNTHESIS METHOD THEREFOR | 株式会社神鋼環境ソリューション | 2019-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210070782-A1 | METHOD FOR SYNTHESIZING BORONATE ESTER COMPOUND, SODIUM SALT OF BORONATE ESTER COMPOUND, AND METHOD FOR SYNTHESIZING THE SAME | BRSK1, BRSK2, BRI3BP | MAOB 1343/4885KDM4E 2475/4885RAB9A 1083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.